Valerie Palmieri, James LaFrance
Vermillion has named Valerie Palmieri president and CEO effective Jan. 1. Current CEO James LaFrance will continue to serve as chairman of the company's board.
Palmieri is currently Vermillion's COO. Prior to joining the company in October, she was president of Momentum Consulting and served as a strategic advisor to the company. Before that she was national vice president of anatomic pathology operations at Laboratory Corporation of America.
Pacific Biosciences has appointed Kathy Ordoñez to the board of directors. For the last 30 years, she has held leadership positions in the life sciences and diagnostics industries, including as senior vice president of Quest Diagnostics, CEO of Celera, founder of Celera Diagnostics, and president and CEO of Roche Molecular Systems.
Claritas Genomics has appointed Patrick Terry as chief commercial officer. As CCO, Terry will expand Claritas' reach to pediatric hospitals and patients. Terry is chairman of Gray Group Ventures and was a founder of Genomic Health. Previously, he and his wife, Sharon Terry, founded PXE International to accelerate research into the rare genetic disease pseudoxanthoma elasticum. He has co-founded and advised multiple life science ventures, including two applied genetics companies. He was a principal advisor with Scientia Advisors and co-founded the Personalized Medicine Coalition, the European Personalized Medicine Association, and the International Genetic Alliance.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.